Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Dynamics of actomyosin filaments in the contractile ring revealed by ultrastructural analysis.

Genes to cells : devoted to molecular & cellular mechanisms·2023

Same author

Synthetic augmentation of bilirubin metabolism in human pluripotent stem cell-derived liver organoids.

Stem cell reports·2023

Same author

iPSC-derived type IV collagen α5-expressing kidney organoids model Alport syndrome.

Communications biology·2023

Same author

Engraftment of allogeneic iPS cell-derived cartilage organoid in a primate model of articular cartilage defect.

Nature communications·2023

Same author

B1 SINE-binding ZFP266 impedes mouse iPSC generation through suppression of chromatin opening mediated by reprogramming factors.

Nature communications·2023

Same author

Generation of human induced pluripotent stem cells (CHULAi001-A) from peripheral blood mononuclear cells of a glucose-6-phosphate dehydrogenase (G6PD) deficient subject carrying the Viangchan mutation.

Stem cell research·2022

Search research articles

Related Experiment Video

Updated: Jun 6, 2026

Intracerebral Transplantation and In Vivo Bioluminescence Tracking of Human Neural Progenitor Cells in the Mouse Brain

Intracerebral Transplantation and In Vivo Bioluminescence Tracking of Human Neural Progenitor Cells in the Mouse Brain

Published on: January 27, 2022

iPS cells for transplantation.

Keisuke Okita¹

¹Department of Reprogramming Science, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan. okita@cira.kyoto-u.ac.jp

Current Opinion in Organ Transplantation

|December 15, 2010

Summary

This summary is machine-generated.

Induced pluripotent stem (iPS) cells offer potential for drug discovery and cell therapies. While progress is being made, further research is crucial to address safety and quality concerns for medical applications.

More Related Videos

Intrasplenic Transplantation of Hepatocytes After Partial Hepatectomy in NOD.SCID Mice

Intrasplenic Transplantation of Hepatocytes After Partial Hepatectomy in NOD.SCID Mice

Published on: February 10, 2018

Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells

Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells

Published on: October 24, 2019

Related Experiment Videos

Last Updated: Jun 6, 2026

Intracerebral Transplantation and In Vivo Bioluminescence Tracking of Human Neural Progenitor Cells in the Mouse Brain

Intracerebral Transplantation and In Vivo Bioluminescence Tracking of Human Neural Progenitor Cells in the Mouse Brain

Published on: January 27, 2022

Intrasplenic Transplantation of Hepatocytes After Partial Hepatectomy in NOD.SCID Mice

Intrasplenic Transplantation of Hepatocytes After Partial Hepatectomy in NOD.SCID Mice

Published on: February 10, 2018

Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells

Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells

Published on: October 24, 2019

Area of Science:

Stem Cell Biology
Regenerative Medicine
Drug Discovery

Background:

Induced pluripotent stem (iPS) cells derived from patient somatic cells hold promise for regenerative medicine and drug discovery.
Significant challenges remain regarding the safety and efficacy of iPS cell-based therapies.
Current research focuses on overcoming these obstacles for clinical translation.

Purpose of the Study:

To review the current state of induced pluripotent stem (iPS) cell technology.
To identify key challenges hindering the clinical application of iPS cells.
To explore recent advancements in iPS cell generation and therapeutic potential.

Main Methods:

Review of recent scientific literature on iPS cell generation and application.
Analysis of safety concerns and quality control measures for iPS cells.
Examination of differentiation potential and therapeutic outcomes in preclinical models.

Main Results:

Generation of integration-free iPS cells from noninvasive tissues is now feasible.
Differences in gene expression, epigenetics, and differentiation potential exist between iPS and embryonic stem (ES) cells.
Transplantation of iPS cell-derived tissues showed therapeutic benefits in a rodent disease model.
Advancements include gene correction, cell fate switching, and generation of HLA-typed iPS cells.

Conclusions:

Human iPS cells can generate functional cells for transplantation therapies (e.g., neuronal, blood, retinal).
Recent progress suggests potential solutions for iPS cell-related challenges.
Further improvements in safety and quality are essential for the medical application of iPS cells.